These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26822803)

  • 1. Optimum combination therapy regimens for HIV/HCV infection.
    Rey D; Muret P; Piroth L
    Expert Rev Anti Infect Ther; 2016; 14(3):299-309. PubMed ID: 26822803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.
    Rockstroh JK
    Liver Int; 2015 Jan; 35 Suppl 1():51-5. PubMed ID: 25529087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current treatment options for hepatitis C patients co-infected with HIV.
    Rockstroh JK; Hardy WD
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):689-95. PubMed ID: 26799571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simeprevir for the treatment of hepatitis C and HIV/hepatitis C co-infection.
    Flanagan S; Crawford-Jones A; Orkin C
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):691-704. PubMed ID: 25209158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms.
    Cooper CL; Klein MB
    HIV Med; 2014 Nov; 15(10):621-4. PubMed ID: 24802099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug Interactions.
    Chan J; Chung RT
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):147-163. PubMed ID: 28263458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A changing paradigm: management and treatment of the HCV/HIV-co-infected patient.
    Abutaleb A; Sherman KE
    Hepatol Int; 2018 Nov; 12(6):500-509. PubMed ID: 30238230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions of hepatitis C direct-acting antivirals in the HIV-infected person.
    El-Sherif O; Back D
    Curr HIV/AIDS Rep; 2015 Sep; 12(3):336-43. PubMed ID: 26159742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.
    Esposito I; Labarga P; Barreiro P; Fernandez-Montero JV; de Mendoza C; Benítez-Gutiérrez L; Peña JM; Soriano V
    Expert Opin Drug Saf; 2015; 14(9):1421-34. PubMed ID: 26212044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct-acting Antivirals for HIV/HCV Co-infected Individuals: As Good as it Gets?
    Bruno G; Saracino A
    Curr HIV Res; 2017; 15(6):422-433. PubMed ID: 29119934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1.
    Salmon-Ceron D; Arvieux C; Bourlière M; Cacoub P; Halfon P; Lacombe K; Pageaux GP; Pialoux G; Piroth L; Poizot-Martin I; Rosenthal E; Pol S; ; ; ;
    Liver Int; 2014 Jul; 34(6):869-89. PubMed ID: 24138548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.
    Smolders EJ; Smit C; de Kanter C; Dofferhoff A; Arends JE; Brinkman K; Rijnders B; van der Valk M; Reiss P; Burger DM;
    HIV Med; 2018 Mar; 19(3):216-226. PubMed ID: 29194939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; McNicholl IR
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing treatment in HIV/HCV coinfection.
    Puoti M; Rossotti R; Travi G; Panzeri C; Morreale M; Chiari E; Cocca G; Orso M; Moioli MC
    Dig Liver Dis; 2013 Sep; 45 Suppl 5():S355-62. PubMed ID: 24091116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key drug-drug interactions with direct-acting antiviral in HIV-HCV coinfection.
    El-Sherif O; Khoo S; Solas C
    Curr Opin HIV AIDS; 2015 Sep; 10(5):348-54. PubMed ID: 26248122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.
    Murata M; Furusyo N; Ogawa E; Mitsumoto F; Hiramine S; Ikezaki H; Takayama K; Shimizu M; Toyoda K; Kainuma M; Hayashi J
    J Infect Chemother; 2014 May; 20(5):320-4. PubMed ID: 24477330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials.
    Shafran SD
    Clin Infect Dis; 2015 Oct; 61(7):1127-34. PubMed ID: 26060286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial.
    Doyle MA; Singer J; Lee T; Muir M; Cooper C
    Trials; 2016 Jul; 17(1):331. PubMed ID: 27439433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV-HIV co-infected patients: no longer a 'special' population?
    Sulkowski MS
    Liver Int; 2016 Jan; 36 Suppl 1():43-6. PubMed ID: 26725896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Majority of HIV/HCV Patients Need to Switch Antiretroviral Therapy to Accommodate Direct Acting Antivirals.
    Cope R; Pickering A; Glowa T; Faulds S; Veldkamp P; Prasad R
    AIDS Patient Care STDS; 2015 Jul; 29(7):379-83. PubMed ID: 26066094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.